We specialize in a range of formulation and drug delivery technologies, from conventional liposomes, PEGylated liposomes for drug delivery to polymer microspheres and nanoparticles for enhanced drug delivery. We have strong and broad expertise and over years of experience in the drug delivery field. Our mission is to become the partner of choice as a leader in drug delivery, particularly in formulating challenging compounds with liposomes, polymers and other novel nano-enabled delivery technologies.
We provide contract services of drug delivery formulation developments for basic research, formulation feasibility studies, process development and scale-up, formulation characterization, analytical and nonclinical services. We also offer a large number of pre-formed liposome, biopolymer & synthetic polymer reagents.
At CD Bioparticles, we work closely with customers and collaborators to find the drug delivery solution that best fits their needs and our experts support clients though all stages of the development process, from formulation development to preclinical trials. We have successfully provided services and/or products to customers from university labs, research institutes and pharmaceutical/biotech industries from all over the world.
Overview
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 27, 2026 | CD Bioparticles Launches Advanced Normal Organoids Kits to Accelerate 3D Biological Research | CD Bioparticle launches Normal Organoids Kits(Human-Derived) for basic research, drug screening, toxicology evaluation, and regenerative medicine. NEW YORK, NY, UNITED STATES, May 27, 2026 /EINPresswire.com/ -- CD Bioparticles, a leading ma... |
| Mar 26, 2026 | CD Bioparticles Launches Extrahepatic RNA Delivery Services to to Advance Nucleic Acid Therapeutics | CD Bioparticles announces the launch of comprehensive Extrahepatic RNA Delivery services. NEW YORK, NY, UNITED STATES, March 26, 2026 /EINPresswire.com/ -- CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery produ... |
| Jan 26, 2026 | CD Bioparticles Announces Advanced Engineering Platform for OMV-Based Bacterial Vaccine Development | CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and oncology research. NEW YORK, NY, UNITED STATES, January 26, 2026 /EINPresswire.com/ -- CD Bioparticles, a leading manufactur... |
| Apr 28, 2025 | CD Bioparticles Introduces New Range of Kits for Advanced Exosome Labeling & Purification | CD Bioparticles has announced the launch of its new comprehensive line of kits for Exosome Labeling & Purification. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- CD Bioparticles, a leading manufacturer and supplier o... |
| Mar 24, 2025 | CD Bioparticles Launches New Exosome Identification (WB Marker) Products to Simplify Exosome Research | CD Bioparticles launches a new line of research products for Exosome Identification (WB markers). NEW YORK, NY, UNITED STATES, March 24, 2025 /EINPresswire.com/ -- CD Bioparticles, a leading manufacturer and supplier of numerous drug delive... |
| Feb 22, 2025 | CD Bioparticles Launches Exosome Extraction Kits to Support Exosome Research | CD Bioparticles recently announced the availability of its new line of Exosome Extraction Kits. NEW YORK, NY, UNITED STATES, February 21, 2025 /EINPresswire.com/ -- CD Bioparticles, a leading manufacturer and supplier of numerous drug deliv... |
| Jan 13, 2025 | Amruth Group positioned for growth in 2025 | Milwaukee-based Amruth Group, a startup making waves in the skincare industry, is gearing up for an exciting 2025. Building on the success of its anti-aging facial cream, the company is planning to expand its product line, explore new paten... |
| Jun 15, 2023 | CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications | CD Bioparticles has launched a new line of Locust Bean Gum for researchers. NEW YORK, UNITED STATES, June 15, 2023/EINPresswire.com/ -- CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, ha... |
| May 19, 2023 | CD Bioparticles Launches New Alginic Acids for Research Applications | CD Bioparticles has launched a new line of alginic acids with advanced technical platforms for drug delivery research. SHIRLEY, NEW YORK, UNITED STATES, May 19, 2023/EINPresswire.com/ -- CD Bioparticles, a leading manufacturer and supplier ... |
Reviews 0
FAQ about CD Bioparticles
What has the press written about CD Bioparticles?
Parsers VC has collected 11 articles mentioning CD Bioparticles, among them “CD Bioparticles Launches Advanced Normal Organoids Kits to Accelerate 3D Biological Research” (May 27, 2026) and “CD Bioparticles Launches Extrahepatic RNA Delivery Services to to Advance Nucleic Acid Therapeutics” (Mar 26, 2026).
Is CD Bioparticles still active?
Yes, CD Bioparticles is active; its latest activity on Parsers VC dates from Jul 27, 2026.